Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01473030 · ClinicalTrials.gov registry record
Long-term Effects of Dutasteride on Architectural and Nuclear Morphometric Features of Benign Prostate Tissue
A clinical trial, sponsored by University of Illinois at Chicago.
- Completed
- Registry status
- 80
- Enrollment target
NCT01473030: Completed study, sponsored by University of Illinois at Chicago.
NCT01473030 is a clinical trial that has completed, run by University of Illinois at Chicago. The registered enrollment target is 80 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01473030 has completed, sponsored by University of Illinois at Chicago.
- COMPLETED
- Registry status
- 80 participants
- Enrollment target
Study Summary
The overall goal of this project is to quantify the long-term effects of dutasteride on the architectural and nuclear features of benign prostate tissue, using state-of-the art digital image analysis techniques. The ultimate result will be a multivariable morphological "signature" that could provide a useful indicator of an individual's degree of drug response.
Primary Outcome
To characterize and quantify the effects of dutasteride on histological (architectural) features of benign prostate tissue via comparison of a random sample of Year 4 biopsy specimens from the dutasteride and placebo groups.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 80 participants |
| Start Date | 2011-11 |
| Est. Completion | 2018-12 |
What the finished NCT01473030 record still lists
NCT01473030 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 80 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT01473030 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01473030 about?
NCT01473030 is a clinical study titled "Long-term Effects of Dutasteride on Architectural and Nuclear Morphometric Features of Benign Prostate Tissue". The overall goal of this project is to quantify the long-term effects of dutasteride on the architectural and nuclear features of benign prostate tissue, using state-of-the art digital image analysis techniques. The ultimate result will be a multivariable morphological "signature" that could provide...
What is the current status of trial NCT01473030?
This trial is currently completed. The enrollment target is 80 participants. The study started on 2011-11. Estimated completion is 2018-12.
Who is sponsoring clinical trial NCT01473030?
This trial is sponsored by University of Illinois at Chicago, which has 430 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01243931 · 80 participants · NA
Optical Coherence Tomography Guided Transepithelial Phototherapeutic Keratectomy
- NCT01659203 · 80 participants · Phase 1
Proton or Photon RT for Retroperitoneal Sarcomas
- NCT01803451 · 80 participants · Early Phase 1
Glucagon-like Peptide 1, Glucose Metabolism and Gastric Bypass
- NCT01964859 · 80 participants · Phase 2
Feasibility Study for Fibroblast Autologous Skin Grafts
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia